Dissociating the Cognitive Effects of Levodopa versus Dopamine Agonists in a Neurocomputational Model of Learning in Parkinson’s Disease

Publisher： Karger

E-ISSN： 1660-2862|11|2|102-111

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.11, Iss.2, 2012-10, pp. : 102-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Dopamine Agonists on Neuropsychiatric Symptoms of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. : 206-209

Karger

Access to resources Recommend Favorite

An Autoradiographic Study on the Pathogenesis of Levodopa-Induced Dyskinesia: Regulation of Dopamine Transporter by Levodopa in a Rat Model of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 1, 2011-08 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 244-246

Karger

Access to resources Recommend Favorite

Olfactory Deficits and Cognitive Dysfunction in Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 179-182

Karger

Access to resources Recommend Favorite

Caenorhabditis elegans as a Model System for Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 4, Iss. 2-3, 2007-06 ,pp. : 199-217

Karger

Access to resources Recommend Favorite